XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$144.12
-0.92 (-0.63%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$145.38
Prev Close$145.04
Day Range$143.59 — $148.93
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
9.1%
From 52W Low
+116.2%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $144.12 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,944.28
Annual Income$9.94
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $283.54 | -0.86% | 520.47B |
| AMGN | $438.82 | -1.14% | 252.64B |
| GILD | $166.53 | -1.45% | 208.95B |
| VRTX | $520.66 | -2.94% | 134.82B |
| REGN | $923.34 | -2.35% | 98.38B |
| MRNA | $199.33 | +1.29% | 90.54B |
| NTRA | $289.92 | +0.15% | 45.90B |
| RVMD | $159.43 | -0.24% | 37.37B |
| BIIB | $247.13 | -1.70% | 37.21B |
| ROIV | $38.96 | +0.59% | 28.64B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Nov 19, 2026 at 10:42 PM ET